These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 21425229)
1. Engineering an allosteric binding site for aminoglycosides into TEM1-β-Lactamase. Volkov AN; Barrios H; Mathonet P; Evrard C; Ubbink M; Declercq JP; Soumillion P; Fastrez J Chembiochem; 2011 Apr; 12(6):904-13. PubMed ID: 21425229 [TBL] [Abstract][Full Text] [Related]
2. Engineering allosteric regulation into the hinge region of a circularly permuted TEM-1 beta-lactamase. Mathieu V; Fastrez J; Soumillion P Protein Eng Des Sel; 2010 Sep; 23(9):699-709. PubMed ID: 20591901 [TBL] [Abstract][Full Text] [Related]
3. Role of the omega-loop in the activity, substrate specificity, and structure of class A beta-lactamase. Banerjee S; Pieper U; Kapadia G; Pannell LK; Herzberg O Biochemistry; 1998 Mar; 37(10):3286-96. PubMed ID: 9521648 [TBL] [Abstract][Full Text] [Related]
4. Modulation of effector affinity by hinge region mutations also modulates switching activity in an engineered allosteric TEM1 beta-lactamase switch. Kim JR; Ostermeier M Arch Biochem Biophys; 2006 Feb; 446(1):44-51. PubMed ID: 16384549 [TBL] [Abstract][Full Text] [Related]
5. NMR-based analysis of aminoglycoside recognition by the resistance enzyme ANT(4'): the pattern of OH/NH3(+) substitution determines the preferred antibiotic binding mode and is critical for drug inactivation. Revuelta J; Vacas T; Torrado M; Corzana F; Gonzalez C; Jiménez-Barbero J; Menendez M; Bastida A; Asensio JL J Am Chem Soc; 2008 Apr; 130(15):5086-103. PubMed ID: 18366171 [TBL] [Abstract][Full Text] [Related]
6. Engineered Amp C β-lactamase as a fluorescent screening tool for class C β-lactamase inhibitors. Tsang MW; Chan PH; So PK; Ma DL; Tsang CW; Wong KY; Leung YC Anal Chem; 2011 Mar; 83(6):1996-2004. PubMed ID: 21338058 [TBL] [Abstract][Full Text] [Related]
7. Fluorescein-labeled beta-lactamase mutant for high-throughput screening of bacterial beta-lactamases against beta-lactam antibiotics. Chan PH; Chan KC; Liu HB; Chung WH; Leung YC; Wong KY Anal Chem; 2005 Aug; 77(16):5268-76. PubMed ID: 16097768 [TBL] [Abstract][Full Text] [Related]
8. Structural aspects for evolution of beta-lactamases from penicillin-binding proteins. Meroueh SO; Minasov G; Lee W; Shoichet BK; Mobashery S J Am Chem Soc; 2003 Aug; 125(32):9612-8. PubMed ID: 12904027 [TBL] [Abstract][Full Text] [Related]
9. Thermodynamics of aminoglycoside binding to aminoglycoside-3'-phosphotransferase IIIa studied by isothermal titration calorimetry. Ozen C; Serpersu EH Biochemistry; 2004 Nov; 43(46):14667-75. PubMed ID: 15544337 [TBL] [Abstract][Full Text] [Related]
10. Ligand binding and allostery can emerge simultaneously. Liang J; Kim JR; Boock JT; Mansell TJ; Ostermeier M Protein Sci; 2007 May; 16(5):929-37. PubMed ID: 17400921 [TBL] [Abstract][Full Text] [Related]
11. Atomic resolution structures of CTX-M beta-lactamases: extended spectrum activities from increased mobility and decreased stability. Chen Y; Delmas J; Sirot J; Shoichet B; Bonnet R J Mol Biol; 2005 Apr; 348(2):349-62. PubMed ID: 15811373 [TBL] [Abstract][Full Text] [Related]
12. An engineered calmodulin-based allosteric switch for Peptide biosensing. Meister GE; Joshi NS Chembiochem; 2013 Aug; 14(12):1460-7. PubMed ID: 23825049 [TBL] [Abstract][Full Text] [Related]
13. Refined crystal structure of beta-lactamase from Citrobacter freundii indicates a mechanism for beta-lactam hydrolysis. Oefner C; D'Arcy A; Daly JJ; Gubernator K; Charnas RL; Heinze I; Hubschwerlen C; Winkler FK Nature; 1990 Jan; 343(6255):284-8. PubMed ID: 2300174 [TBL] [Abstract][Full Text] [Related]
15. Structure and kinetics of the beta-lactamase mutants S70A and K73H from Staphylococcus aureus PC1. Chen CC; Smith TJ; Kapadia G; Wäsch S; Zawadzke LE; Coulson A; Herzberg O Biochemistry; 1996 Sep; 35(38):12251-8. PubMed ID: 8823158 [TBL] [Abstract][Full Text] [Related]
16. Rational design of a novel fluorescent biosensor for beta-lactam antibiotics from a class A beta-lactamase. Chan PH; Liu HB; Chen YW; Chan KC; Tsang CW; Leung YC; Wong KY J Am Chem Soc; 2004 Apr; 126(13):4074-5. PubMed ID: 15053574 [TBL] [Abstract][Full Text] [Related]
18. Crystal structure of extended-spectrum beta-lactamase Toho-1: insights into the molecular mechanism for catalytic reaction and substrate specificity expansion. Ibuka AS; Ishii Y; Galleni M; Ishiguro M; Yamaguchi K; Frère JM; Matsuzawa H; Sakai H Biochemistry; 2003 Sep; 42(36):10634-43. PubMed ID: 12962487 [TBL] [Abstract][Full Text] [Related]
19. NMR characterization of an engineered domain fusion between maltose binding protein and TEM1 beta-lactamase provides insight into its structure and allosteric mechanism. Wright CM; Majumdar A; Tolman JR; Ostermeier M Proteins; 2010 May; 78(6):1423-30. PubMed ID: 20034108 [TBL] [Abstract][Full Text] [Related]
20. Communication between the active site and the allosteric site in class A beta-lactamases. Meneksedag D; Dogan A; Kanlikilicer P; Ozkirimli E Comput Biol Chem; 2013 Apr; 43():1-10. PubMed ID: 23314151 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]